Achieving chronic kidney disease treatment targets in renal transplant recipients: Results from a cross-sectional study in Spain

Transplantation

Volumn 87, Issue 9, 2009, Pages 1340-1346

  Marcén, Roberto ^a   Del Castillo, Domingo ^b   Capdevila, Luis ^c   Fernandez Fresnedo, Gema ^d   Rodrigo, Emilio ^d   Cantarell, Carmen ^c   Fernández Rodriguez, Ana ^a   López Oliva, María O ^b   Camps, Joaquin ^c   Aljama, Pedro ^b   Ortuño, Joaquín ^a   Arias, Manuel ^d  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Hospital Reina Sofa   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Chronic kidney disease; Clinical care; Cross sectional study; Graft function; Kidney transplant recipients

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANEMIC AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VITAMIN D;

ADULT; AGED; ANEMIA; ARTICLE; CALCIUM METABOLISM; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE METABOLISM; PREVALENCE; PRIORITY JOURNAL; SPAIN; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANEMIA; BLOOD PRESSURE; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OUTPATIENTS; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SPAIN; TISSUE DONORS;

EID: 67649616510     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a23837     Document Type: Article

References (35)

1. Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311.
2. Meier-Kriesche H-U, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39(suppl 1): S1.
4. Levey AS, Eckard KU, Tsukamoto, et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int 2005; 67: 2089.
5. Abbud-Filho M, Adams PL, Alberu' J, et al. A report of the Lisbon conference on the care of the kidney transplant recipient. Transplantation2007; 83: S1.
6. Gill JS, Tonelli M, Mix CH, et al. The change in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1636.
7. Karthikeyan V, Karpinski J, Nair RC, et al. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2003; 4: 262.
8. Marce'n R, Pascual J, Tenorio M, et al. Chronic kidney disease in renal transplant recipients. Transplant Proc 2005; 37: 3718.
9. Ferna'ndez-Fresnedo G, de Francisco A, Ruiz JC, et al. Relevance of chronic kidney disease classification (K/DOQI) in renal transplant patients. Transplant Proc 2006; 38: 2402.
10. Ansell D, Udayarej UP, Steenkamp R, et al. Chronic renal failure in kidney transplant recipients. Do they receive optimum care?: Data from the UK renal registry. Am J Transplant 2007; 7: 1167.
11. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(suppl 3): S1.
12. Molnar MZ, Novak M, Ambrus NM, et al. Anemia in kidney transplant recipients. Clin Transplant 2005; 19: 825.
13. Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: A European survey. Am J Transplant 2003; 3: 835.
14. Al-Koury S, Shah N, Afzali B, et al. Post-transplantation anaemia in adult and paediatric renal allograft recipients-Guy's hospital experience. Nephrol Dial Transplant 2006; 21: 1974.
15. National Kidney Foundation. K/DOQI clinical practice guidelines for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47(suppl 3): S1.
16. EDTA-ERA. European best practice guidelines. Nephrol Dial Transplant2000; 15(suppl 4): 1.
17. Shan N, Al-Koury S, Afzali B, et al. Posttransplantation anemia in adult renal allograft recipients: Prevalence and predictors. Am J Transplant2006; 81: 1112.
18. Evenepoel P, Claes K, Kuypers D, et al. Natural history of parathyroid function and calcium metabolism after kidney transplantation: A single-centre study. Nephrol Dial Transplant 2004; 19: 1281.
19. Torres A, Rodríguez AP, Concepcio'n MT, et al. Parathyroid function in long-term renal transplant patients: Importance of pre-transplantPTH concentrations. Nephrol Dial Transplant 1998; 13(suppl 3): 94.
20. Heaf J, Tvedegaard E, Kanstrup I-L, et al. Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant2003; 13: 268.
21. Ferna'ndez-Fresnedo G, Rodrigo E, Valero R, et al. Traditional cardiovascular risk factors as clinical markers alter kidney transplantation. Transplant Rev 2006; 20: 88.
22. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071.
23. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998; 53: 217.
24. Tutone VK, Mark PB, Steward GA, et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant2005; 19: 181.
25. Ferna'ndez-Fresnedo G, Palomar R, Escallada R, et al. Hypertension and long-term renal allograft survival: Effect of early glomerular filtration rate. Nephrol Dial Transplant 2001; 16(suppl 1): 105.
26. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43(5 suppl 1): S1.
27. Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant2005; 5: 2725.
28. Premasathian NC, Muehrer R, Brazy PC, et al. Blood pressure control in kidney transplantation: Therapeutic implications. J Hum Hypertens2004; 18: 871.
29. Hiremath S, Fergusson D, Doucette S, et al. Renin angiotensin blockade in kidney transplantation: A systematic review of the evidence. Am J Transplant 2007; 7: 2350.
30. Kasiske B, Cosio FG, Beto J, et al. Clinical practice guidelines for managing dyslipemias in kidney transplant patients: A report from the Managing Dyslipemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Quality Initiative. Am J Transplant 2004; 7(4 suppl): 13.
31. Aakhus S, Dahl K, Wideroe TE. Hyperlipidaemia in renal transplant recipients. J Intern Med 1996; 239: 407.
32. Brown JH, Murphy BG, Douglas AF, et al. Influence of immunosuppressive therapy on lipoprotein (a) and other lipoproteins following renal transplantation. Nephron 1997; 75: 277.
33. Aakhus S, Dahl K, Wideroe TE. Cardiovascular disease in stable renal transplant patients in Norway: Morbidity and mortality during a 5-yr follow-up. Clin Transplant 2004; 18: 596.
34. Marce'n R, Morales JM, Arias M, et al. Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain. J Am Soc Nephrol2006; 17: S286.
35. Holdaas H, Fellström B, Jardine AG, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 2003; 361: 2024.